JP2012524548A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012524548A5 JP2012524548A5 JP2012507405A JP2012507405A JP2012524548A5 JP 2012524548 A5 JP2012524548 A5 JP 2012524548A5 JP 2012507405 A JP2012507405 A JP 2012507405A JP 2012507405 A JP2012507405 A JP 2012507405A JP 2012524548 A5 JP2012524548 A5 JP 2012524548A5
- Authority
- JP
- Japan
- Prior art keywords
- bovis
- attenuated
- bovine
- pathogenic
- bacterial strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000588622 Moraxella bovis Species 0.000 claims 46
- 230000002238 attenuated effect Effects 0.000 claims 19
- 230000001580 bacterial effect Effects 0.000 claims 19
- 241000283690 Bos taurus Species 0.000 claims 17
- 230000002163 immunogen Effects 0.000 claims 17
- 238000000034 method Methods 0.000 claims 16
- 230000001717 pathogenic effect Effects 0.000 claims 15
- 241001465754 Metazoa Species 0.000 claims 11
- 208000015181 infectious disease Diseases 0.000 claims 11
- 241000589902 Leptospira Species 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 229960005486 vaccine Drugs 0.000 claims 5
- 244000052769 pathogen Species 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 241000589562 Brucella Species 0.000 claims 3
- 241000193403 Clostridium Species 0.000 claims 3
- 206010015548 Euthanasia Diseases 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 238000012360 testing method Methods 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- 241000711895 Bovine orthopneumovirus Species 0.000 claims 2
- 241000701922 Bovine parvovirus Species 0.000 claims 2
- 241000589874 Campylobacter fetus Species 0.000 claims 2
- 241000606161 Chlamydia Species 0.000 claims 2
- 241000709691 Enterovirus E Species 0.000 claims 2
- 241000606831 Histophilus somni Species 0.000 claims 2
- 241000588748 Klebsiella Species 0.000 claims 2
- 241000204031 Mycoplasma Species 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000005847 immunogenicity Effects 0.000 claims 2
- 230000002906 microbiologic effect Effects 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 230000007918 pathogenicity Effects 0.000 claims 2
- 241000186046 Actinomyces Species 0.000 claims 1
- 241000223836 Babesia Species 0.000 claims 1
- 241000223838 Babesia bovis Species 0.000 claims 1
- 241000702673 Bovine rotavirus Species 0.000 claims 1
- 241001453279 Campylobacter fetus subsp. fetus Species 0.000 claims 1
- 241001656807 Clostridium haemolyticum Species 0.000 claims 1
- 241000193468 Clostridium perfringens Species 0.000 claims 1
- 241000193466 Clostridium septicum Species 0.000 claims 1
- 241000193449 Clostridium tetani Species 0.000 claims 1
- 241000186216 Corynebacterium Species 0.000 claims 1
- 241000673115 Cryptosporidium hominis Species 0.000 claims 1
- 241000223936 Cryptosporidium parvum Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 241001581234 Histophilus Species 0.000 claims 1
- 241000589929 Leptospira interrogans Species 0.000 claims 1
- 241001550390 Leptospira interrogans serovar Canicola Species 0.000 claims 1
- 241000186779 Listeria monocytogenes Species 0.000 claims 1
- 241001293418 Mannheimia haemolytica Species 0.000 claims 1
- 241000186359 Mycobacterium Species 0.000 claims 1
- 241001147662 Neospora caninum Species 0.000 claims 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 1
- 208000026681 Paratuberculosis Diseases 0.000 claims 1
- 241000606856 Pasteurella multocida Species 0.000 claims 1
- 206010051986 Pneumatosis Diseases 0.000 claims 1
- 206010037742 Rabies Diseases 0.000 claims 1
- 206010051497 Rhinotracheitis Diseases 0.000 claims 1
- 241001546666 Salmonella enterica subsp. enterica serovar Newport Species 0.000 claims 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims 1
- 241000555745 Sciuridae Species 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 241000193985 Streptococcus agalactiae Species 0.000 claims 1
- 241000194042 Streptococcus dysgalactiae Species 0.000 claims 1
- 241000194054 Streptococcus uberis Species 0.000 claims 1
- 241000223996 Toxoplasma Species 0.000 claims 1
- 241000186064 Trueperella pyogenes Species 0.000 claims 1
- 241000202898 Ureaplasma Species 0.000 claims 1
- 206010051511 Viral diarrhoea Diseases 0.000 claims 1
- 230000005875 antibody response Effects 0.000 claims 1
- 244000309743 astrovirus Species 0.000 claims 1
- 201000008680 babesiosis Diseases 0.000 claims 1
- 229940038704 clostridium perfringens Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940023064 escherichia coli Drugs 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940051027 pasteurella multocida Drugs 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 229940030998 streptococcus agalactiae Drugs 0.000 claims 1
- 229940115920 streptococcus dysgalactiae Drugs 0.000 claims 1
- 229940115922 streptococcus uberis Drugs 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17254309P | 2009-04-24 | 2009-04-24 | |
| US61/172,543 | 2009-04-24 | ||
| PCT/US2010/032149 WO2010124154A1 (en) | 2009-04-24 | 2010-04-23 | Vaccines comprising attenuated mycoplasma bovis strains and method for the attenuation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012524548A JP2012524548A (ja) | 2012-10-18 |
| JP2012524548A5 true JP2012524548A5 (enExample) | 2013-06-13 |
| JP5793808B2 JP5793808B2 (ja) | 2015-10-14 |
Family
ID=42331013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507405A Active JP5793808B2 (ja) | 2009-04-24 | 2010-04-23 | 弱毒化マイコプラズマ・ボビス株を含むワクチン及び弱毒化の方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9339533B2 (enExample) |
| EP (1) | EP2421556B1 (enExample) |
| JP (1) | JP5793808B2 (enExample) |
| KR (1) | KR101880888B1 (enExample) |
| CN (1) | CN102458461B (enExample) |
| AR (1) | AR076413A1 (enExample) |
| AU (1) | AU2010238689B2 (enExample) |
| BR (1) | BRPI1013836B1 (enExample) |
| CA (1) | CA2758733C (enExample) |
| CL (1) | CL2011002639A1 (enExample) |
| CO (1) | CO6460761A2 (enExample) |
| DK (1) | DK2421556T3 (enExample) |
| ES (1) | ES2630209T3 (enExample) |
| HU (1) | HUE033618T2 (enExample) |
| MX (1) | MX342443B (enExample) |
| NZ (1) | NZ595914A (enExample) |
| PL (1) | PL2421556T3 (enExample) |
| SG (2) | SG175323A1 (enExample) |
| UY (1) | UY32570A (enExample) |
| WO (1) | WO2010124154A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008030619A2 (en) * | 2006-09-07 | 2008-03-13 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| CL2008003202A1 (es) * | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| AU2009309041B2 (en) | 2008-10-31 | 2016-02-04 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| US8440203B2 (en) * | 2009-11-06 | 2013-05-14 | Intervet Inc. | Methods of immunizing pregnant heifers at three months of gestation |
| CN102294026A (zh) * | 2010-11-17 | 2011-12-28 | 赤峰博恩药业有限公司 | 奶牛链球菌乳房炎灭活疫苗及其制备方法 |
| US9175049B2 (en) | 2012-10-24 | 2015-11-03 | The United States Of America, As Represented By The Secretary Of Agriculture | Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection |
| JP6370807B2 (ja) * | 2013-12-18 | 2018-08-08 | 旭化成株式会社 | 乳汁中のストレプトコッカス属の菌を検出する方法 |
| CN103800901B (zh) * | 2014-01-27 | 2015-12-09 | 内蒙古华希生物科技有限公司 | 链球菌以及将其灭活得到的奶牛乳房炎疫苗 |
| CN108135989B (zh) | 2015-08-14 | 2022-08-09 | 硕腾服务有限责任公司 | 牛支原体组合物 |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN107815439A (zh) * | 2016-09-14 | 2018-03-20 | 华威特（江苏）生物制药有限公司 | 牛传染性鼻气管炎病毒jsm株及其应用 |
| CN107759674B (zh) * | 2017-09-26 | 2021-12-28 | 中国农业科学院哈尔滨兽医研究所 | 一种牛支原体免疫相关性蛋白、含有该蛋白的检测试剂盒及其在牛支原体抗体检测中的用途 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN109847060A (zh) * | 2019-04-19 | 2019-06-07 | 黑龙江八一农垦大学 | 牛多杀性巴氏杆菌病、溶血性曼氏杆菌病二联灭活疫苗及其制备方法 |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| CN111733094B (zh) * | 2020-05-29 | 2022-09-09 | 内蒙古民族大学 | 一种牛源蜡样芽孢杆菌及其应用 |
| AR124849A1 (es) | 2021-02-11 | 2023-05-10 | Intervet Int Bv | Vacuna para mycoplasma bovis |
| CN115869392B (zh) * | 2022-12-12 | 2025-06-24 | 内蒙古华希生物科技有限公司 | 牛病毒性腹泻病毒、传染性鼻气管炎病毒、副流感病毒3型和支原体四联灭活疫苗 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8296498A (en) | 1997-07-10 | 1999-02-08 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
| EP0965639A1 (en) | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| CA2390613A1 (en) * | 1999-11-08 | 2001-05-17 | Biomune | Vaccines for mycoplasma bovis and methods of use |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
| US20030147914A1 (en) * | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| WO2003004051A2 (en) * | 2001-07-02 | 2003-01-16 | Pfizer Products Inc. | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| EP1420636A2 (en) | 2001-08-28 | 2004-05-26 | Pfizer Products Inc. | Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions |
| US7217420B2 (en) * | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
| DE102004025452A1 (de) | 2004-05-19 | 2006-01-19 | Boehringer Ingelheim Vetmedica Gmbh | Vakzine enthaltend BVDV |
| US20070009545A1 (en) * | 2005-07-07 | 2007-01-11 | Joachim Frey | Mycoplasma subunit vaccine |
| WO2008030619A2 (en) | 2006-09-07 | 2008-03-13 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| CN100419073C (zh) * | 2006-09-28 | 2008-09-17 | 中国兽医药品监察所 | 猪喘气病活疫苗及其生产方法 |
| US20090068231A1 (en) | 2007-09-11 | 2009-03-12 | Wyeth | Live attenuated mycoplasma strains |
| TW200918666A (en) * | 2007-09-11 | 2009-05-01 | Wyeth Corp | Attenuated mycoplasma gallisepticum strains |
| CL2008003202A1 (es) | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| NZ589981A (en) | 2008-07-03 | 2012-11-30 | Univ Iowa State Res Found Inc | Cattle vaccines comprising a disrupted M. bovis bacterium |
| AU2009309041B2 (en) * | 2008-10-31 | 2016-02-04 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
-
2010
- 2010-04-22 UY UY0001032570A patent/UY32570A/es active IP Right Grant
- 2010-04-23 CA CA2758733A patent/CA2758733C/en active Active
- 2010-04-23 PL PL10717367T patent/PL2421556T3/pl unknown
- 2010-04-23 JP JP2012507405A patent/JP5793808B2/ja active Active
- 2010-04-23 MX MX2011010976A patent/MX342443B/es active IP Right Grant
- 2010-04-23 CN CN201080028660.0A patent/CN102458461B/zh active Active
- 2010-04-23 SG SG2011077617A patent/SG175323A1/en unknown
- 2010-04-23 AU AU2010238689A patent/AU2010238689B2/en active Active
- 2010-04-23 NZ NZ595914A patent/NZ595914A/en unknown
- 2010-04-23 AR ARP100101382A patent/AR076413A1/es active IP Right Grant
- 2010-04-23 KR KR1020117024968A patent/KR101880888B1/ko active Active
- 2010-04-23 BR BRPI1013836A patent/BRPI1013836B1/pt active IP Right Grant
- 2010-04-23 HU HUE10717367A patent/HUE033618T2/en unknown
- 2010-04-23 US US12/766,084 patent/US9339533B2/en active Active
- 2010-04-23 DK DK10717367.6T patent/DK2421556T3/en active
- 2010-04-23 WO PCT/US2010/032149 patent/WO2010124154A1/en not_active Ceased
- 2010-04-23 EP EP10717367.6A patent/EP2421556B1/en active Active
- 2010-04-23 ES ES10717367.6T patent/ES2630209T3/es active Active
- 2010-04-23 SG SG10201401784WA patent/SG10201401784WA/en unknown
-
2011
- 2011-10-21 CL CL2011002639A patent/CL2011002639A1/es unknown
- 2011-11-11 CO CO11154171A patent/CO6460761A2/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012524548A5 (enExample) | ||
| Nicholas et al. | An experimental vaccine for calf pneumonia caused by Mycoplasma bovis: clinical, cultural, serological and pathological findings | |
| KR101315092B1 (ko) | 로소니아 인트라셀룰라리스를 포함하는 면역원성 조성물 | |
| EP2007419B1 (en) | Vaccine against mycoplasma prrsv | |
| US20140105930A1 (en) | Bovine vaccines and methods | |
| EP3723795A1 (en) | A vaccine for protection against streptococcus suis | |
| JP2019513722A5 (enExample) | ||
| CA2409813C (en) | Compositions and methods for treatment of mucosal infections | |
| EP3876980A1 (en) | A vaccine for protection against streptococcus suis | |
| Patil et al. | Virulence pattern of Avibacterium paragallinarum isolates studied from Indian field condition | |
| Pelton | Regulation of bacterial trafficking in the nasopharynx | |
| Pan et al. | Progress in the application of Salmonella vaccines in poultry: A mini review | |
| US20170246286A1 (en) | Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use | |
| CA2931139A1 (en) | Swine vaccine against prrs and lawsonia intracellularis | |
| CN102481350A (zh) | 针对猪胸膜肺炎的疫苗和得到这样的疫苗的方法 | |
| KR102040665B1 (ko) | 약독화된 폐렴구균 균주를 포함하는 약제학적 조성물 및 이의 용도 | |
| CN101420975A (zh) | 抗支原体和prrsv的疫苗 | |
| Li et al. | Co-administration of attenuated Mycoplasma hyopneumoniae 168 strain with bacterial DNA enhances the local and systemic immune response after intranasal vaccination in pigs | |
| AU2014234452B2 (en) | Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica | |
| Maes | Mycoplasma hyopneumoniae infections in pigs: update on epidemiology and control | |
| JP2020517744A (ja) | 弱毒化した肺炎球菌菌株を含む薬剤学的組成物およびその用途 | |
| WO2022072431A1 (en) | Novel pasteurella multocida strains and vaccines having hyac and nanp deletions | |
| JP2017525726A5 (enExample) | ||
| RU2017110230A (ru) | Вакцина для производства продукции животноводства | |
| US12071636B2 (en) | Pasteurella multocida strains and vaccines having hyaC and nanP deletions |